Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence M Silverman

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The Journal of Molecular Diagnostics : JMD|February 14, 2016
The Challenges of Applying Massively Parallel Sequencing to Newborn Screening for Cystic FibrosisLawrence M Silverman
Clinical Chemistry|December 23, 2004
Genotype-phenotype correlations: assessing the influence of sequence variants on the clinical phenotypeLawrence M Silverman, Mani S Mahadevan
Clinical Chemistry|May 26, 2005
Genotype-phenotype correlations (II): assessing the influence of sequence variants on the clinical phenotype in multifactorial disordersLawrence M Silverman, Theodore M Mifflin
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 17, 2006
Molecular diagnostics: a historical perspectiveGregory J Tsongalis, Lawrence M Silverman
Current Sports Medicine Reports|March 12, 2014
Chronotropic incompetence precedes silent pulmonary embolismKarunasai Mahadevan, Lawrence M Silverman, Daniel M Becker
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 17, 2004
CFTR mutation distribution among U.S. Hispanic and African American individuals: evaluation in cystic fibrosis patient and carrier screening populationsElaine A Sugarman, Elizabeth M Rohlfs, Lawrence M Silverman, et al.
Clinical Chemistry|June 1, 2010
Direct-to-consumer genotyping: are we ready for a brave new world?Lew Bender, Lawrence M Silverman, Mary Beth Dinulos, et al.
Clinical Chemistry|January 31, 2018
Restricted IgG-Kappa and Free Alpha-Heavy-Chain Bands in an Asymptomatic 62-Year-Old ManMin Yu, David E Bruns, Jerry A Katzmann, et al.
American Journal of Obstetrics and Gynecology|March 9, 2006
Acceptance of fragile X premutation genetic screening in women with ovarian dysfunctionLisa M Pastore, Logan B Karns, JoAnn V Pinkerton, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|May 15, 2012
Elevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserveLisa M Pastore, Steven L Young, Valerie L Baker, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The Journal of Molecular Diagnostics : JMD|February 14, 2016
The Challenges of Applying Massively Parallel Sequencing to Newborn Screening for Cystic FibrosisLawrence M Silverman
Clinical Chemistry|December 23, 2004
Genotype-phenotype correlations: assessing the influence of sequence variants on the clinical phenotypeLawrence M Silverman, Mani S Mahadevan
Clinical Chemistry|May 26, 2005
Genotype-phenotype correlations (II): assessing the influence of sequence variants on the clinical phenotype in multifactorial disordersLawrence M Silverman, Theodore M Mifflin
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 17, 2006
Molecular diagnostics: a historical perspectiveGregory J Tsongalis, Lawrence M Silverman
Current Sports Medicine Reports|March 12, 2014
Chronotropic incompetence precedes silent pulmonary embolismKarunasai Mahadevan, Lawrence M Silverman, Daniel M Becker
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 17, 2004
CFTR mutation distribution among U.S. Hispanic and African American individuals: evaluation in cystic fibrosis patient and carrier screening populationsElaine A Sugarman, Elizabeth M Rohlfs, Lawrence M Silverman, et al.
Clinical Chemistry|June 1, 2010
Direct-to-consumer genotyping: are we ready for a brave new world?Lew Bender, Lawrence M Silverman, Mary Beth Dinulos, et al.
Clinical Chemistry|January 31, 2018
Restricted IgG-Kappa and Free Alpha-Heavy-Chain Bands in an Asymptomatic 62-Year-Old ManMin Yu, David E Bruns, Jerry A Katzmann, et al.
American Journal of Obstetrics and Gynecology|March 9, 2006
Acceptance of fragile X premutation genetic screening in women with ovarian dysfunctionLisa M Pastore, Logan B Karns, JoAnn V Pinkerton, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|May 15, 2012
Elevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserveLisa M Pastore, Steven L Young, Valerie L Baker, et al.
Pageof 2